1. Home
  2. ONCO vs STRR Comparison

ONCO vs STRR Comparison

Compare ONCO & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • STRR
  • Stock Information
  • Founded
  • ONCO 2018
  • STRR 1985
  • Country
  • ONCO United States
  • STRR United States
  • Employees
  • ONCO N/A
  • STRR N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ONCO Health Care
  • STRR Health Care
  • Exchange
  • ONCO Nasdaq
  • STRR Nasdaq
  • Market Cap
  • ONCO 9.4M
  • STRR 7.0M
  • IPO Year
  • ONCO 2022
  • STRR N/A
  • Fundamental
  • Price
  • ONCO $0.45
  • STRR $2.22
  • Analyst Decision
  • ONCO
  • STRR
  • Analyst Count
  • ONCO 0
  • STRR 0
  • Target Price
  • ONCO N/A
  • STRR N/A
  • AVG Volume (30 Days)
  • ONCO 9.9M
  • STRR 6.7K
  • Earning Date
  • ONCO 04-10-2025
  • STRR 03-21-2025
  • Dividend Yield
  • ONCO N/A
  • STRR N/A
  • EPS Growth
  • ONCO N/A
  • STRR N/A
  • EPS
  • ONCO N/A
  • STRR N/A
  • Revenue
  • ONCO $1,870,605.00
  • STRR $50,375,000.00
  • Revenue This Year
  • ONCO N/A
  • STRR $15.58
  • Revenue Next Year
  • ONCO N/A
  • STRR $36.27
  • P/E Ratio
  • ONCO N/A
  • STRR N/A
  • Revenue Growth
  • ONCO N/A
  • STRR 2.22
  • 52 Week Low
  • ONCO $0.32
  • STRR $2.05
  • 52 Week High
  • ONCO $21.40
  • STRR $5.35
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 36.47
  • STRR 51.69
  • Support Level
  • ONCO $0.58
  • STRR $2.10
  • Resistance Level
  • ONCO $0.70
  • STRR $2.23
  • Average True Range (ATR)
  • ONCO 0.06
  • STRR 0.08
  • MACD
  • ONCO -0.01
  • STRR 0.02
  • Stochastic Oscillator
  • ONCO 7.41
  • STRR 86.84

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.

Share on Social Networks: